These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 2468763)

  • 1. Changes in brain monoamine metabolism during withdrawal from chronic oral self-administration of morphine and in response to a morphine challenge in the withdrawn state.
    Ahtee L; Attila LM; Carlson KR; Haikala H
    J Pharmacol Exp Ther; 1989 Apr; 249(1):303-10. PubMed ID: 2468763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Augmentation of morphine-induced changes in brain monoamine metabolism after chronic naltrexone treatment.
    Ahtee L; Attila LM; Carlson KR
    J Pharmacol Exp Ther; 1990 Nov; 255(2):803-8. PubMed ID: 2243351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cerebral dopamine and noradrenaline turnover and effects of morphine test dose in rats withdrawn from 20 days' morphine treatment.
    Attila LM; Ahtee L
    Med Biol; 1983; 61(5):249-257. PubMed ID: 6686987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral catecholamine depletion in mice withdrawn from repeated morphine treatment and development of tolerance to the enhancing effect of morphine on noradrenaline depletion.
    Etemadzadeh E
    J Pharmacol Exp Ther; 1993 Aug; 266(2):749-55. PubMed ID: 8355206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonin and dopamine turnover after acute and chronic morphine administration.
    Papeschi R; Theiss P; Herz A
    Arzneimittelforschung; 1974 Jul; 24(7):1017-9. PubMed ID: 4408355
    [No Abstract]   [Full Text] [Related]  

  • 6. Changes in the brain biogenic monoamines of rats, induced by piracetam and aniracetam.
    Petkov VD; Grahovska T; Petkov VV; Konstantinova E; Stancheva S
    Acta Physiol Pharmacol Bulg; 1984; 10(4):6-15. PubMed ID: 6535371
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of morphine on locomotor activity and striatal monoamine metabolism in nicotine-withdrawn mice.
    Vihavainen T; Mijatovic J; Piepponen TP; Tuominen RK; Ahtee L
    Behav Brain Res; 2006 Oct; 173(1):85-93. PubMed ID: 16846651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ontogeny of mu opiate tolerance and dependence in the rat: antinociceptive and biochemical studies.
    Windh RT; Little PJ; Kuhn CM
    J Pharmacol Exp Ther; 1995 Jun; 273(3):1361-74. PubMed ID: 7791109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-release of noradrenaline and dopamine in the prefrontal cortex after acute morphine and during morphine withdrawal.
    Devoto P; Flore G; Pira L; Diana M; Gessa GL
    Psychopharmacology (Berl); 2002 Mar; 160(2):220-4. PubMed ID: 11875641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence for acute tolerance to the behavioral effects of lindane: concomitant changes in regional monoamine status.
    Llorens J; Suñol C; Tusell JM; Rodríguez-Farré E
    Neurotoxicology; 1991; 12(4):697-705. PubMed ID: 1724556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retardation of cerebral dopamine turnover after morphine withdrawal and its enhanced acceleration by acute morphine administration in rats.
    Attila LM; Ahtee L
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Sep; 327(3):201-7. PubMed ID: 6541759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of chronic Fos-related antigens in rat brain by chronic morphine administration.
    Nye HE; Nestler EJ
    Mol Pharmacol; 1996 Apr; 49(4):636-45. PubMed ID: 8609891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic morphine administration decreases 5-hydroxytryptamine and 2-hydroxyindoleacetic acid content in the brain of rats.
    Ahtee L
    Med Biol; 1980 Feb; 58(1):38-44. PubMed ID: 6155571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clozapine and cocaine effects on dopamine and serotonin release in nucleus accumbens during psychostimulant behavior and withdrawal.
    Broderick PA; Hope O; Okonji C; Rahni DN; Zhou Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jan; 28(1):157-71. PubMed ID: 14687870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regionally specific changes in central brain monoamine levels by 2,4-dichlorophenoxyacetic acid in acute treated rats.
    Bortolozzi A; Duffard RO; Rubio M; Sturtz N; Evangelista de Duffard AM
    Neurotoxicology; 1998 Dec; 19(6):839-51. PubMed ID: 9863773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in catecholaminergic pathways innervating paraventricular nucleus and pituitary-adrenal axis response during morphine dependence: implication of alpha(1)- and alpha(2)-adrenoceptors.
    Laorden ML; Fuertes G; González-Cuello A; Milanés MV
    J Pharmacol Exp Ther; 2000 May; 293(2):578-84. PubMed ID: 10773031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of chronic administration of lithium chloride on the development of dopamine receptor sensitivity during morphine withdrawal in rats].
    Allikmets LKh; Nurk AM
    Biull Eksp Biol Med; 1981 Nov; 92(11):571-2. PubMed ID: 6274448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agmatine inhibits morphine-induced locomotion sensitization and morphine-induced changes in striatal dopamine and metabolites in rats.
    Wei XL; Su RB; Wu N; Lu XQ; Zheng JQ; Li J
    Eur Neuropsychopharmacol; 2007 Dec; 17(12):790-9. PubMed ID: 17604969
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The involvement of noradrenergic transmission in the morphine-induced locomotor hyperactivity in mice withdrawn from repeated morphine treatment.
    Airio J; Ahtee L
    Br J Pharmacol; 1999 Apr; 126(7):1609-19. PubMed ID: 10323593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of chronic administration of morphine and its withdrawal on the rat brain and spinal cord dopamine D1 receptors.
    Bhargava HN; Gulati A
    Prog Clin Biol Res; 1990; 328():307-10. PubMed ID: 2304954
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.